121 related articles for article (PubMed ID: 35941044)
21. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
23. SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p.
Cui F; Hao ZX; Li J; Zhang YL; Li XK; He JX
Mol Genet Genomic Med; 2020 May; 8(5):e1195. PubMed ID: 32130794
[TBL] [Abstract][Full Text] [Related]
24. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features?
Cavallaro PM; Stafford C; Cauley CE; Berger DL; Bordeianou L; Kunitake H; Francone T; Ricciardi R
Dis Colon Rectum; 2021 May; 64(5):545-554. PubMed ID: 33939386
[TBL] [Abstract][Full Text] [Related]
25. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.
Sholl LM; Barletta JA; Yeap BY; Chirieac LR; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1193-8. PubMed ID: 20631605
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.
Yoon HI; Park KH; Lee EJ; Keum KC; Lee CG; Kim CH; Kim YB
Cancer Res Treat; 2016 Apr; 48(2):473-82. PubMed ID: 26323639
[TBL] [Abstract][Full Text] [Related]
28. High SOX2 levels predict better outcome in non-small cell lung carcinomas.
Velcheti V; Schalper K; Yao X; Cheng H; Kocoglu M; Dhodapkar K; Deng Y; Gettinger S; Rimm DL
PLoS One; 2013; 8(4):e61427. PubMed ID: 23620753
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
31. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
[TBL] [Abstract][Full Text] [Related]
32. KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
Clin Lung Cancer; 2018 Jul; 19(4):e489-e501. PubMed ID: 29627316
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
Li M; Ma G; Li X; Zhou Q
Med Sci Monit; 2022 Jul; 28():e936898. PubMed ID: 35891604
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
35. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
37. Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients With Crohn's Disease.
Yasuhara M; Beppu N; Uchino M; Ikeuchi H; Matsuda I; Hirota S; Ikeda M; Tomita N
Dis Colon Rectum; 2021 Apr; 64(4):409-419. PubMed ID: 33394780
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
[TBL] [Abstract][Full Text] [Related]
40. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
Lim YJ; Song C; Jeon SH; Kim K; Chie EK
Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
